Gilead will award $4.5 million over three years to support the partnership, which focuses on Black communities in the Southern U.S., according to an Aug. 17 press release from Gilead.
CDC research indicates inequities drive higher rates of HIV infection and worse clinical outcomes among Black Americans.
“This collaboration will focus on the barriers that are most prevalent in Black communities and help increase access to HIV care to produce better outcomes for Black people,” Rashad Burgess, Gilead vice president of advancing health and Black equity, said in the release.
According to the release, the partnership is intended to close critical gaps in care by addressing the following issues:
- Expanding understanding of the effect COVID-19 has on the healthcare delivery system in Black communities
- Realigning HIV services to reflect COVID-19’s impact.
- Providing focused training for culturally appropriate HIV care with stigma-reducing strategies.
- Increasing access and use of culturally appropriate care for Black people affected by HIV.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
